16 Dec 2023 - 17 Dec 2023
09:00 AM - 06:00 PM
7th Annual Year End Review in Lung Cancer
Program Director: Dr Kumar Prabhash
7th Annual Year End Review in Lung Cancer 2023 December 16th & 17th, 2023 Venue: The Westing Mumbai Garden City.
7th Annual Year End Review in Lung Cancer Day 2
Date : 17 Dec 2023
| Dr Minit Shah Issues in the management of Geriatric Cases Advanced stage lung cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Vanita Noronha | Lung cancer management in geriatric population | CRSF | 12:00 AM - 12:00 AM |
| Dr Ashay Karpe | 6th Master Class in Lung Cancer | Geriatric Oncology Workshop | CRSF | 12:00 AM - 12:00 AM |
| Dr Sabita Jiwnani Surgery | After NACT In Locally Advanced Lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Ritika Harjani | Radiation In LALC | CRSF | 12:00 AM - 12:00 AM |
| Dr Amit Agrawal | Concurrent Chemotherapy | CRSF | 12:00 AM - 12:00 AM |
| Dr Prabhat Malik | Adjuvant IO in LALC | CRSF | 12:00 AM - 12:00 AM |
| Dr Kunal Jobanputra Maintenance | Therapy In Locally Advanced Stage III NSCLC | CRSF | 12:00 AM - 12:00 AM |
| Dr Darshit Shah Debate Dr Gunjesh Kumar Singh Immunotherapy Sequencing In Early Stage Resectable Lun | 12:00 AM - 12:00 AM |
| Case For VIVA NSCLC Locally Advanced Moderator Dr Nikhil Kalyani Case Presenters Dr Joyita Sarkar D | 12:00 AM - 12:00 AM |
| Dr Pradeep Chandrani | Interpretation Of NGS What A Clinician Should Know | CRSF | 12:00 AM - 12:00 AM |
| Dr Abhinav Zawar | Mechanism Of Resistance To Osimeritinib In EGFR Mutated Lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Alok Goel | Post Osimeritinib Options In EGFR Mutated Lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Vijay Patil | Uncommon EGFR mutations | CRSF | 12:00 AM - 12:00 AM |
| Case Base VIVA | Driver Mutated NSCLC Moderator |Dr Anu Rajpurohit Dr Amol Rathod Dr Shreyas Shelke | 12:00 AM - 12:00 AM |
| Dr Sameer Shrirangwar | First Line TKI Something In EGFR | CRSF | 12:00 AM - 12:00 AM |
| Dr Mansi Sharma | Interpretation Of NGS What A Clinician Should Know | CRSF | 12:00 AM - 12:00 AM |
7th Annual Year End Review in Lung Cancer Day 1
Date : 16 Dec 2023
| 6th Master Class | Dr Soujanya Mynalli | Different Spectrum of Lung Cancer Presentation | 12:00 AM - 12:00 AM |
| Dr Kunal Gala | Image Guided Tissue Sampling | 12:00 AM - 12:00 AM |
| Panel Discussion Lung Cancer Case Management Evolving Role of Mulitimodality and Multidisciplinary D | 12:00 AM - 12:00 AM |
| Dr Anil Tibdewal | 6th Master Class in Lung Cancer 2023, Day-1 | 12:00 AM - 12:00 AM |
| Dr Virendra Tiwari | Surgery Early Stage Lung Cancer | 12:00 AM - 12:00 AM |
| Dr Suhas Aagre | Early Stage Lung Cancer Adjuvant Chemotherapy | 12:00 AM - 12:00 AM |
| Dr Ajay Kumar Singh | Adjuvant Targeted Therapy In EGFR Mutated Early Stage Lung Cancer | 12:00 AM - 12:00 AM |
| Dr Suparna Rao | Neoadjuvant and Adjuvant Immunotherapy in Early stage Lung Cancer | 12:00 AM - 12:00 AM |
| Dr Anup Toshniwal | Follow Up After Treatment Completion In Early Stage Lung Cancer | 12:00 AM - 12:00 AM |
| Case Based Viva | Moderator: Dr Murad Lala | 6th Master Class in Lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Rajiv Kaushal Interpretation | Of PD1 1 MSI TMB In NSCLC | CRSF | 6th Master Class in Lung Cancer | 12:00 AM - 12:00 AM |
| Dr Navneet Singh | Selection Of 1st Line Immunotherapy Pdl1 50% & 1% In NSCLC | 12:00 AM - 12:00 AM |
| Dr Amol Kotalwar | Selection Of 1st Line Immunotherapy In PDL1 Negative & Non Driver Mutations | 12:00 AM - 12:00 AM |
| Dr Ashay Karpe | Biomarkers For Predicting Ef Of IO Non PDL1 NON MSI NON TMB | 12:00 AM - 12:00 AM |
| Dr Kshitij Joshi | Use Of Immunotherapy In Patients With Poor Performance Status | 12:00 AM - 12:00 AM |
| Dr Hollis Dsouza | Use Of IO In Driver Mutated Patients | 12:00 AM - 12:00 AM |
| Dr Tanmoy Kumar | Mandal Mechanism Of Resistance On IO | 6th Master Class in Lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Swaratika Majumdar | Therapy Post Progression On IO Chemotherapy | 12:00 AM - 12:00 AM |
| Case Based | Viva| Moderator: Dr Govind Babu Kanakasetty : 6th Master Class in Lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Dr Sabita Jiwnani | Newer surgical techniques improving outcome | CRSF | 6th Master Class | 12:00 AM - 12:00 AM |
| Dr Anup Toshniwal | Beyond Operability in Early Lung Cancer | 6th Master Class in Lung Cancer | 12:00 AM - 12:00 AM |
| Dr. Kaustav Talapatra | Whats new in radiation techniques Mumbai in early lung Cancer | CRSF | 12:00 AM - 12:00 AM |
| Panel Discussion | Dr Prriya Eshpuniyani Treating NSCLC Stage I IIIA How to Achieve Best Outcomes | 12:00 AM - 12:00 AM |
| Panel Discussion Dr Prriya Eshpuniyani Treating NSCLC Stage I IIIA How to Achieve Best Outcomes | 12:00 AM - 12:00 AM |
| Dr Sewanti Limaye Role and place of anti angiogenics in advanced NSCLC | 12:00 AM - 12:00 AM |
Molecular oncology Workshop (Day-1)
Date : 16 Dec 2023
| Dr Sudha Murthy | MRD in NSCLC | 12:00 AM - 12:00 AM |
| Welcome and Introduction | Dr Anuradha Choughule | Molecular Workshop | 12:00 AM - 12:00 AM |
| Dr Trupti Pai | Copy number variations–IHC vs FISH vs NGS | 12:00 AM - 12:00 AM |
| Dr Ravins Dohare | Kinesin family in lung adenocarcinoma | 12:00 AM - 12:00 AM |
| Dr Sonal Rajiv Bakshi | PPM1D and other germline alterations in a Familial lung cancer | 12:00 AM - 12:00 AM |
| Dr Rajiv Kaushal | Gene fusion detection IHC vs FISH vs NGS | CRSF | 12:00 AM - 12:00 AM |
| Dr Sabarinathan Radhakrishnan | Immunoproteasome expression in solid tumours | CRSF | 12:00 AM - 12:00 AM |
| Dr Lepakshi Kuruba | BRAF Mutation in NSCLC | CRSF | 12:00 AM - 12:00 AM |
| Dr Vidya Veldore | Integrative panel for liquid biopsy and tissue biopsy NGS | 12:00 AM - 12:00 AM |
| Dr Prerana Jha | Landscape of actionable alterations using targeted next generation sequencing | 12:00 AM - 12:00 AM |
| Dr Ajay Kumar Singh | Panel Discussion Molecular Tumor Board | 12:00 AM - 12:00 AM |
| Molecular Oncology Workshop | Closing Remarks | Dr Pratik Chandrani | 12:00 AM - 12:00 AM |
Program Director:
Dr Kumar Prabhash
Contact Person
Garima Vashishtha
info@hcmpl.com
8178985238
Download